Eli Lilly

Iterative Health

Cambridge

Iterative Health develops technology that can benefit patients anywhere, regardless of socioeconomic or geographic barriers.

Superluminal Medicines

Boston

Superluminal Medicines is a generative biological and chemical company that innovates drug discovery and development processes.

Maxion Therapeutics

Cambridge

Ion channel and GPCR drug discovery using innovative KnotBody technology

AltPep

Seattle

AltPep provides a novel approach for tackling amyloid diseases, with diagnostic, therapeutic and anti-biofilm applications.

Dicerna Pharmaceuticals

Lexington

Dicerna, a wholly owned subsidiary of Novo Nordisk, is focused on driving innovation in RNAi (ribonucleic acid interference) to selectively target and silence genes that cause or contribute to disease.

Lycia Therapeutics

South San Francisco

Lycia is a Series B biotech company built on a platform developed by academic founder Professor Carolyn Bertozzi at Stanford, arising from Stanford research, with potential to deliver next-generation therapeutics for difficult-to-treat dise